Friday, 17 Nov 2017

You are here

Kidney transplant improves survival in GPA

Even with currently available treatment modalities, ESRD is a common complication of Granulomatosis with polyangiitis (GPA) occurring in approximately 25% of patients. Transplantation frequently used for ESRD but has not been applied widely in GPA.

Current analysis is aimed at evaluation of benefits of transplantation in extending surgical or prisons with GPA comparing to remaining on waiting list.

1,556 patients with ESRD due to GPA who were registered in the United States Renal Data System (USRDS) and were waitlisted for a renal transplant between 1995 and 2015 were included in this analysis and adjusted for sociodemographic covariates (e.g., age, gender) as well as comorbidities (e.g., diabetes, cardiovascular disease (CVD). 977 (63%) of these patients received a transplant. The majority were male (60%) and white (84%).

In fully-adjusted analyses, transplanted patients had a 59% lower risk of death compared to those who remained on the waitlist (RR 0.41, 95% CI 0.34-0.49).   

 

Specifically, study reports lower risk of death from CVD (HR 0.06, 95% CI 0.03-0.1) and infection (HR 0.3 95% CI 0.2-0.6). There was no difference in the risk of cause-specific death from cancer (HR 0.5 95% CI 0.2-1.2). The study emphasizes the need to identify obstacles to transplantation in patient with EXRD due to GPA. Additionally, modalities aimed at reducing the risk of CVD and infection in patients on the waitlist would likely improve survival.


Add new comment

More Like This

The RheumNow Week in Review - 17 November 2017

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com. This week he covers FDA warnings on gout drugs, steroid use in Australia, biosimilars lost savings and methotrexate hepatotoxicity in psoriatic arthritis (PsA).

Podcast of ACR17 - Day 4

Care to learn what you missed at last weeks ACR 2017 meeting in San Diego?  Here are 4 one hour audio podcasts - each with a compliation of 2-4 minute reports from Drs. Cush, Kavanaugh, the RheumNow Faculty and other rheumatology thought leaders and researchers.  Another good way to learn from RheumNow.

The ACR17 RheumNow Week in Review - 10 November 2017

This special edition of the RheumNow Week in Review covers highlights of selected sessions from the 2017 ACR annual meeting in San Diego. Dr. Jack Cush reviews lupus and the microbiome, daily podcasts, pregnancy and lactation, osteoporosis drug holidays and screening for pulmonary hypertension.

Many thanks to the RheumNow Faculty for their work and expertise!

Podcast of ACR 17 - Day 3

Check out this compilation of our ACR17 Day 3 broadcasts, merged into a single one hour podcast !

ACR 2017 - Day 3 and 4 Highlights

Day 3 at the annual meeting was rich with information. Yet the most anticipated and best attended session was the Late Breaking Abstracts and the session revealing the new ACR/NPF Guidelines for Psoriatic Arthritis (more on the latter in another report).  Day 4 was full of review sessions and a modicum of original content and for me, the 7:30AM Rheumatology Roundup.